Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.20)
# 373
Out of 4,826 analysts
80
Total ratings
35%
Success rate
30.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $4.77 | +109.86% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $11.98 | +66.94% | 12 | Apr 14, 2025 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $6 → $4 | $1.92 | +108.88% | 8 | Apr 9, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.93 | +7.98% | 12 | Apr 3, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $45.25 | -11.60% | 10 | Apr 1, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $8 → $5.5 | $0.62 | +786.67% | 11 | Mar 28, 2025 | |
| CRVS Corvus Pharmaceuticals | Reiterates: Buy | $11 | $3.57 | +208.12% | 3 | Mar 26, 2025 | |
| VSTM Verastem | Maintains: Buy | $7 → $10 | $7.02 | +42.55% | 13 | Mar 24, 2025 | |
| MYO Myomo | Maintains: Buy | $7.5 → $9.5 | $4.75 | +100.00% | 5 | Mar 12, 2025 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $100 | $3.66 | +2,632.24% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.45 | +1,968.97% | 1 | Dec 5, 2022 |
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $4.77
Upside: +109.86%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $11.98
Upside: +66.94%
CASI Pharmaceuticals
Apr 9, 2025
Maintains: Buy
Price Target: $6 → $4
Current: $1.92
Upside: +108.88%
Cytosorbents
Apr 3, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.93
Upside: +7.98%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $45.25
Upside: -11.60%
Plus Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $8 → $5.5
Current: $0.62
Upside: +786.67%
Corvus Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $3.57
Upside: +208.12%
Verastem
Mar 24, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $7.02
Upside: +42.55%
Myomo
Mar 12, 2025
Maintains: Buy
Price Target: $7.5 → $9.5
Current: $4.75
Upside: +100.00%
Kazia Therapeutics
Jul 12, 2024
Reiterates: Buy
Price Target: $100
Current: $3.66
Upside: +2,632.24%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.45
Upside: +1,968.97%